accelerated approval of tazemetostat for follicular lymphoma
Published 4 years ago • 221 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
1:16
dr. leonard on the fda approval of tazemetostat in follicular lymphoma
-
1:31
exploring the tazemetostat approval in r/r follicular lymphoma
-
0:57
dr. skarbnik on the approval of tazemetostat in relapsed/refractory follicular lymphoma
-
8:58
john p. leonard, md, on the fda approval of tazemetostat for follicular lymphoma
-
1:48
tazemetostat in combination with lenalidomide and rituximab for r/r follicular lymphoma
-
1:11
dr. maddocks on the role of tazemetostat in ezh2-mutant follicular lymphoma
-
1:35
dr. burke on tazemetostat’s mechanism of action in ezh2-mutated follicular lymphoma
-
0:38
tazemetostat and rituximab in r/r follicular lymphoma
-
3:54
typical diagnostic journey for follicular lymphoma patients
-
1:15
dr. leslie on phase 1b trial of tazemetostat plus lenalidomide/rituximab in follicular lymphoma
-
3:44
etctn p10500: a phase i/expansion study of tazemetostat plus belinostat for r/r nhl
-
1:08
dr. skarbnik on future combination therapies with tazemetostat in follicular lymphoma
-
10:16
tazemetostat for the treatment of r/r fl
-
3:32
tazemetostat for treatment of epitheloid sarcoma (new drug 2020)
-
11:13
fda approval in cll and fl, partial hold lifted in tazmetostat trials, and more
-
6:50
treatment after progression in follicular lymphoma
-
3:46
follicular lymphoma - anti-tumor action of tazometostat
-
4:37
prognosis and treatment of follicular lymphoma
-
56:01
current and future role of ezh1/2 inhibitors in the care of patients with lymphoma